Search Results - "Esanu, A"

Educational intervention for adolescents in order to decrease stigma towards people with mental disorders, cluster randomized controlled trial by Esanu, A, Chihai, J, Esanu, D

Get full text

THE INFLUENCE OF BLOOD PRESSURE VALUES AND OTHER COMPONENTS OF METABOLIC SYNDROME ON RIGHT VENTRICLE TEI INDEX by Sedaia, E., Revenco, V., Esanu, A., Ochisor, V.

Get full text

Predictors of atherosclerotic plaque progression in patients with non-obstructive coronary artery disease by Abras, M., Grib, A., Surev, A., Damascan, S., Pasat, E., Vascenco, A., Esanu, A., Lutica, N.

Get full text

P.7.e.002 - Educational intervention for adolescents in order to decrease stigma towards people with mental disorders, cluster randomized controlled trial by Esanu, A., Chihai, J., Esanu, D.

Get full text

Compulsory admissions of patients with mental disorders : state of the art on ethical and legislative aspects in 40 european countries by Wasserman, D., Apter, G., Baeken, C., Bailey, S., Balazs, J., Bec, C., Bienkowski, P., Bobes, J., Ortiz, M. F. Bravo, Brunn, H., Bôke, Ö., Camilleri, N., Carpiniello, B., Chihai, J., Chkonia, E., Courtet, P., Cozman, D., David, M., Dom, G., Esanu, A., Falkai, P., Flannery, W., Gasparyan, K., Gerlinger, G., Gorwood, P., Gudmundsson, O., Hanon, C., Heinz, A., HEITOR MARQUES DOS SANTOS LEAL DA COSTA, MARIA JOÃO, Hedlund, A., Ismayilov, F., Ismayilov, N., Isometsä, E. T., Izakova, L., Kleinberg, A., Kurimay, T., Reitan, S. Klæbo, Lecic-Tosevski, D., Lehmets, A., Lindberg, N., Lundblad, K. A., Lynch, G., Maddock, C., Malt, U. F., Martin, L., Martynikhin, I., Maruta, N. O., Matthys, F., Mazaliauskiene, R., Mihajlovic, G., Peles, A. Mihaljevic, Miklavic, V., Mohr, P., Ferrandis, M. Munarriz, Musalek, M., Neznanov, N., Ostorharics-Horvath, G., Pajević, I., Popova, A., Pregelj, P., Prinsen, E., Rados, C., Roig, A., Kuzman, M. Rojnic, Samochowiec, J., Sartorius, N., Savenko, Y., Skugarevsky, O., Slodecki, E., Soghoyan, A., Stone, D. S., Taylor-East, R., Terauds, E., Tsopelas, C., Tudose, C., Tyano, S., Vallon, P., Van der Gaag, R. J., Varandas, P., Vavrusova, L., Voloshyn, P., Wancata, J., Wise, J., Zemishlany, Z., Öncü, F., Vahip, S.

“…© The Author(s), 2020. Published by Cambridge University Press on behalf of the European Psychiatric Association. This is an Open Access article, distributed…”
Get full text

Recovery of postischemic brain metabolism and function following treatment with a free radical scavenger and platelet-activating factor antagonists by Gilboe, D D, Kintner, D, Fitzpatrick, J H, Emoto, S E, Esanu, A, Braquet, P G, Bazan, N G

“…We have studied the metabolic and functional effects of two new platelet-activating factor (PAF) antagonists (BN 50726 and BN 50739) and their diluent…”
Get more information

Effect of BN 50739, a new platelet activating factor antagonist, on ischaemia induced ventricular arrhythmias in isolated working rat hearts by Koltai, M, Tosaki, A, Hosford, D, Esanu, A, Braquet, P

“…The aim was to investigate the role of platelet activating factor (PAF) in myocardial ischaemia by using BN 50739, a new specific PAF receptor antagonist with…”
Get more information

Effect of cicletanine on reperfusion-induced arrhythmias and myocardial ion contents: a comparison with furosemide by Koltai, M, Tosaki, A, Berthet, P, Tarrade, T, Esanu, A, Braquet, P

“…We studied the effects of cicletanine, a furopyridine antihypertensive drug, and furosemide, a loop diuretic, on ventricular arrhythmias, such as sustained…”
Get more information

New trends in PAF antagonist research: a new series of potent hetrapazine-derived PAF antagonists by Braquet, P, Esanu, A

Get full text

Evidence that mammalian lignans show endogenous digitalis-like activities by Fagoo, M, Braquet, P, Robin, J P, Esanu, A, Godfraind, T

“…Enterolactone, a lignan that has been identified in biological samples from man and several mammals, shares with ascorbic acid and cardiac glycosides a…”
Get more information

Vascular remodeling and antihypertensive therapy: the example of cicletanine by Chabrier, P E, Esanu, A, Braquet, P

“…Hypertension causes major structural vascular modifications including increase of wall:lumen ratio, vessel wall hypertrophy, and rarefaction of arterioles and…”
Get more information

Cicletanine sulfate : inhibition of anion transport systems and natriuretic activity by GARAY, R. P, ROSATI, C, NAZARET, C, ESANU, A, TARRADE, T, BRAQUET, P

“…In contrast with cicletanine, its urinary sulfoconjugate metabolite (cicletanine sulfate) was active on membrane ion transport in human red blood cells…”
Get full text

Gaps and perspectives of new fluoroquinolones by Neuman, M, Esanu, A

“…The gaps in the present piperazinyl-substituted fluoroquinolones include: (a) gaps in their antibacterial spectrum, varying from one fluoroquinolone to another…”
Get more information

Endogenous lignans--a potential endogenous digitalis by Braquet, P, Senn, N, Robin, J P, Esanu, A, Garay, R P

“…Lignans are natural products formed by oxidative dimerization of monomeric phenols. A few were recently discovered in human and animal urine, semen and blood…”
Get more information

From ginkgolides to N-substituted piperidino-thieno diazepines, a new series of highly potent dual antagonists by Braquet, P, Laurent, J P, Rolland, A, Martin, C, Pommier, J, Hosford, D, Esanu, A

Get more information

Platelet Activating Factor (PAF): A Review of its Effects, Antagonists and Possible Future Clinical Implications (Part I)1 by Koltai, Matyas, Hosford, David, Guinot, Philippe, Esanu, André, Braquet, Pierre

Get full text

Platelet activating factor (PAF). A review of its effects, antagonists and possible future clinical implications (Part I) by Koltai, M, Hosford, D, Guinot, P, Esanu, A, Braquet, P

“…This review is an attempt to summarise recent data on platelet activating factor (PAF) and PAF antagonists from 1988 to the present. This period saw a burst in…”
Get full text

Histamine H1-receptors mediate phosphoinositide and calcium response in cultured smooth muscle cells--interaction with cicletanine (CIC) by Lonchampt, M O, Marche, P, Demerle, C, Girard, A, Cabanie, M, Esanu, A, Chabrier, P E, Braquet, P

“…Smooth muscle cells were cultured from guinea-pig aorta and labelled with 45Ca++ and 32Pi to investigate the possible effect of cicletanine, a new…”
Get full text

PAF. A review of its effects, antagonists and possible future clinical implications (Part II) by Koltai, M, Hosford, D, Guinot, P, Esanu, A, Braquet, P

Get full text

Antithrombotic activity of BN 50341, a structurally new compound with anticalcic and PAF-antagonistic properties by Etienne, A, Baroggi, N, Andries, R, Clostre, F, Esanu, A, Bourgain, R, Braquet, P

“…BN 50341, a new benzazepine derivative, which has been shown to possess a mild anticalcic activity decreased (oral or i.v. administration) and also totally…”
Get more information